Director/PDMR Share Dealings
March 31, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces
that today Ordinary Shares ("Shares") and American Depository Shares ("ADSs")
of the Company, as set out below, have been acquired for the Non-Executive
Directors, being the part of their total fees that are paid in securities for
the period of service from January 1 to March 31, 2014.
Type of Security (1) Number of Securities
Dominic Blakemore Shares 147
William Burns Shares 178
Dr. Steven Gillis ADSs 57
Dr. David Ginsburg ADSs 54
David Kappler Shares 186
Susan Kilsby ADSs 61
Anne Minto Shares 185
David Stout ADSs 59
(1) One ADS is equal to three Shares
The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ
respectively at prices of £29.9876 per Share and $147.90 per ADS.
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a)
of the Disclosure and Transparency Rules.
Deputy Company Secretary
For further information please contact:
Laurie Stelzer firstname.lastname@example.org +1 781 482 0733
Eric Rojas email@example.com +1 781 482 0999
Sarah Elton-Farr firstname.lastname@example.org +44 1256 894157
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal and
Internal Medicine and we are developing treatments for symptomatic conditions
treated by specialist physicians in other targeted therapeutic areas.
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
-0- Mar/31/2014 15:25 GMT
Press spacebar to pause and continue. Press esc to stop.